Literature DB >> 3318813

Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli.

J L Schrimsher1, K Rose, M G Simona, P Wingfield.   

Abstract

Human and mouse granulocyte-macrophage-colony-stimulating factors (hGM-CSF and mGM-CSF, respectively), isolated from Escherichia coli cells expressing the corresponding human and mouse genes, have been characterized. The observed properties of the proteins have been compared with those properties which can be deduced from the DNA sequence alone and the published properties of natural GM-CSFs. The purified E. coli-derived proteins were found to have the expected molecular masses, amino acid compositions and N- and C-terminal amino acid sequences. The finding of 70-90% unprocessed N-terminal methionine for both proteins is discussed. The four Cys residues were found to be involved in two intramolecular disulphide bonds, linking the first and third, and second and fourth Cys residues. This disulphide bond arrangement is probably the one existing in natural material, since, although not glycosylated, both E. coli-derived proteins showed biological activity (colony stimulating assay for hGM-CSF, and cell proliferation assay for mGM-CSF) comparable with that reported for the respective proteins purified from animal cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318813      PMCID: PMC1148387          DOI: 10.1042/bj2470195

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

2.  Spectroscopic determination of tryptophan and tyrosine in proteins.

Authors:  H Edelhoch
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

Review 3.  The granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.

Authors:  A W Burgess; J Camakaris; D Metcalf
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

6.  Methionine or not methionine at the beginning of a protein.

Authors:  F Sherman; J W Stewart; S Tsunasawa
Journal:  Bioessays       Date:  1985-07       Impact factor: 4.345

7.  Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor.

Authors:  A W Burgess; C G Begley; G R Johnson; A F Lopez; D J Williamson; J J Mermod; R J Simpson; A Schmitz; J F DeLamarter
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

8.  Characterization of human interleukin 2 derived from Escherichia coli.

Authors:  S M Liang; B Allet; K Rose; M Hirschi; C M Liang; D R Thatcher
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

9.  Increased biological activity of deglycosylated recombinant human granulocyte/macrophage colony-stimulating factor produced by yeast or animal cells.

Authors:  P Moonen; J J Mermod; J F Ernst; M Hirschi; J F DeLamarter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

10.  Separation of recombinant human interleukin-2 and methionyl interleukin-2 produced in Escherichia coli.

Authors:  T Yamada; K Kato; K Kawahara; O Nishimura
Journal:  Biochem Biophys Res Commun       Date:  1986-03-28       Impact factor: 3.575

View more
  8 in total

1.  Identification of critical regions in mouse granulocyte-macrophage colony-stimulating factor by scanning-deletion analysis.

Authors:  A B Shanafelt; R A Kastelein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.

Authors:  B M Curtis; D E Williams; H E Broxmeyer; J Dunn; T Farrah; E Jeffery; W Clevenger; P deRoos; U Martin; D Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF).

Authors:  P Wingfield; R Benedict; G Turcatti; B Allet; J J Mermod; J DeLamarter; M G Simona; K Rose
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

4.  C-terminal peptide identification by fast atom bombardment mass spectrometry.

Authors:  K Rose; L A Savoy; M G Simona; R E Offord; P Wingfield
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

5.  Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli.

Authors:  A E Proudfoot; D Fattah; E H Kawashima; A Bernard; P T Wingfield
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

6.  Isolation and characterization of a resistant core peptide of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF); confirmation of the GM-CSF amino acid sequence by mass spectrometry.

Authors:  A Tsarbopoulos; B N Pramanik; J E Labdon; P Reichert; G Gitlin; S Patel; V Sardana; T L Nagabhushan; P P Trotta
Journal:  Protein Sci       Date:  1993-11       Impact factor: 6.725

7.  Granulocyte-macrophage colony-stimulating factor mimicry and receptor interactions.

Authors:  J M Von Feldt; C Monfardini; T Kieber-Emmons; D Voet; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

8.  An enzyme-linked immunosorbent assay (ELISA) for quantitation of adducts of granulocyte-macrophage colony stimulating factor (GM-CSF) and human serum albumin (HSA) in stressed solution mixtures.

Authors:  R Kumarasamy; J Bausch; D Kopcha; S Patel; E McGonigle
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.